Cannabis and Your Heart -- What 35 Years of Research Shows

The research is more complex than the headlines suggest.

Let's rise above the stigma -- but let's do it honestly.

Cannabis and cardiovascular health is one of the most important and most misunderstood topics in cannabis research. The headlines swing between "cannabis causes heart attacks" and "cannabis is perfectly safe." Neither is true. The reality, as it usually is in medicine, lives in the middle -- and the research tells a more interesting and more useful story than either extreme.

Today we lay it all out. The good, the bad, and the gaps. Because rising above the stigma does not mean pretending risks do not exist. It means knowing the full picture and making informed decisions.

The 35-Year Study: No Hypertension Link

The Coronary Artery Risk Development in Young Adults study, known as CARDIA, is one of the longest-running cardiovascular studies ever conducted. Researchers tracked a cohort of Black and White young adults for 35 years, measuring cumulative lifetime cannabis use against incident hypertension.

The result: no significant association between cannabis use and risk of developing hypertension. The adjusted hazard ratio was 0.99 with a 95 percent confidence interval of 0.97 to 1.00. That is about as close to "no effect" as epidemiology gets.

The finding held up across every sensitivity analysis the researchers ran -- stratified by sex, race, alcohol use, and tobacco smoking. It held when they used restricted cubic splines. It held when they used an alternative measure of exposure.

For 35 years, in a well-designed longitudinal cohort, cannabis use did not predict high blood pressure.

This matters because hypertension is the single most common modifiable risk factor for cardiovascular disease, stroke, and heart failure. If cannabis caused hypertension, 35 years of data from CARDIA would have found it. They did not.

The Other Side: Acute Cardiovascular Risks

But that is not the whole story. And this is where honest cannabis journalism earns its credibility.

A systematic review published in Heart analyzed data from 24 studies covering 200 million adults. Cannabis users had a 29 percent higher risk of heart attack and a 20 percent higher risk of stroke compared to nonusers. These are observational findings -- they show association, not causation -- but they are consistent across large datasets.

A study presented at the American College of Cardiology found that cannabis users under 50 had a sixfold increased risk of heart attack compared to nonusers, even among people with no other cardiovascular risk factors -- normal blood pressure, healthy cholesterol, no diabetes, no tobacco use.

Research from UC San Francisco found that regular cannabis edible users showed a 56 percent reduction in vascular function -- the ability of blood vessels to relax and expand -- compared to nonusers. Smokers showed a 42 percent reduction.

The mechanism is not fully understood, but researchers hypothesize that THC can affect heart rhythm regulation, increase oxygen demand in the heart muscle, and contribute to endothelial dysfunction -- the inability of blood vessels to properly relax and expand when needed. The risk of heart attack appears to peak about one hour after consumption, which aligns with the known pharmacokinetic timeline of THC reaching peak blood levels.

Dr. Lynn Silver of UCSF emphasized that any method of inhaling cannabis carries risks similar to those of tobacco -- not just for the user, but through secondhand smoke as well. The edibles finding is particularly notable because many consumers assume that avoiding inhalation eliminates cardiovascular risk. The UCSF data suggests otherwise.

It is also worth noting that the majority of these studies did not differentiate between cannabis products by cannabinoid profile. A joint containing 30 percent THC, a balanced tincture with equal CBD and THC, and a CBD-only topical are treated as the same exposure in most epidemiological datasets. This is a significant limitation that future research needs to address.

How to Read These Findings Together



Here is what the research collectively tells us when you put the pieces together:

Cannabis does not appear to cause hypertension over the long term. That is what CARDIA established over 35 years. But cannabis may trigger acute cardiovascular events -- particularly heart attacks and strokes -- through mechanisms related to blood vessel function rather than chronic blood pressure elevation.

The distinction matters clinically. For a 25-year-old with no heart disease risk factors, the absolute risk from cannabis use remains very low even if the relative risk is elevated. For a 60-year-old with existing cardiovascular disease, the acute effects of THC on vascular function and heart rhythm could be genuinely dangerous.

CBD presents a meaningfully different cardiovascular profile from THC. Preclinical research suggests CBD has anti-inflammatory, antioxidant, and vasodilatory properties that may actually protect cardiovascular health. A 2024 review in the British Journal of Pharmacology noted that CBD reduced inflammation and oxidative stress in models of cardiovascular disease, and demonstrated direct vasodilatory effects -- meaning it helped blood vessels relax and expand, the opposite of what THC appears to do acutely.

Animal studies have shown CBD reduces cardiac inflammation, decreases infarct size after induced heart attacks, and improves left ventricular function. These findings remain preclinical -- no large randomized controlled trial has confirmed cardiovascular benefits in humans. But the mechanistic evidence is strong enough that multiple research groups are pursuing clinical trials specifically targeting CBD for heart failure and post-stroke recovery.

The implication for patients is important: not all cannabis products carry the same cardiovascular risk profile. A high-CBD, low-THC formulation may be significantly safer for older adults and people with cardiovascular concerns than a high-THC product. The distinction matters, and it is one that most cannabis coverage ignores.

The honest bottom line: cannabis is not a cardiovascular miracle or a cardiovascular disaster. It is a pharmacologically active substance that interacts with the cardiovascular system in complex ways. Young, healthy people face minimal absolute risk. Older adults with heart conditions should discuss cannabis use with their cardiologist. CBD may offer cardiovascular benefits distinct from THC.

That is what rising above the stigma looks like -- not cherry-picking the studies that make cannabis look perfect, but knowing the full picture and making choices with complete information.